{"id":"cns-stimulant","safety":{"commonSideEffects":[{"rate":null,"effect":"Insomnia"},{"rate":null,"effect":"Nervousness or anxiety"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Increased heart rate or palpitations"},{"rate":null,"effect":"Appetite suppression"},{"rate":null,"effect":"Tremor"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"CNS stimulants work primarily through monoaminergic pathways, either by promoting the release of catecholamines (dopamine and norepinephrine) from presynaptic neurons or by inhibiting their reuptake at the synaptic cleft. This results in increased synaptic concentrations of these neurotransmitters, leading to enhanced neural signaling, increased alertness, improved focus, and elevated mood. Common mechanisms include sympathomimetic activity and inhibition of monoamine oxidase or reuptake transporters.","oneSentence":"CNS stimulants increase the activity of the central nervous system by enhancing the release or blocking the reuptake of neurotransmitters such as dopamine and norepinephrine.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:29:20.959Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Attention-deficit/hyperactivity disorder (ADHD)"},{"name":"Narcolepsy"},{"name":"Fatigue or excessive daytime somnolence"}]},"trialDetails":[{"nctId":"NCT03485417","phase":"PHASE2, PHASE3","title":"Substance Misuse To Psychosis for Stimulants","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2019-06-01","conditions":"Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis), Schizophrenia and Related Disorders, Stimulant Dependence","enrollment":165},{"nctId":"NCT04734080","phase":"PHASE4","title":"Dronabinol in Total Knee Arthroplasty (TKA)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2021-03-09","conditions":"Total Knee Arthroplasty, Opioid Use","enrollment":114},{"nctId":"NCT07179614","phase":"NA","title":"Kentucky Women's Justice Community Overdose Innovation Network - Phase II","status":"NOT_YET_RECRUITING","sponsor":"Michele Staton","startDate":"2026-04-15","conditions":"Overdose Risk, Opioid Use Disorder, Stimulant Use Disorders","enrollment":300},{"nctId":"NCT07490717","phase":"NA","title":"Developing and Testing Innovative Care Pathways for Screening and Treatment of OUD/PTSD in Jails","status":"ENROLLING_BY_INVITATION","sponsor":"University of Arkansas","startDate":"2026-01-20","conditions":"Post-traumatic Stress Disorder (PTSD), Post-traumatic Stress Symptoms, Opioid Use Disorder (OUD)","enrollment":338},{"nctId":"NCT07484217","phase":"PHASE3","title":"Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol","status":"RECRUITING","sponsor":"Axsome Therapeutics, Inc.","startDate":"2026-02-23","conditions":"Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms","enrollment":508},{"nctId":"NCT01571752","phase":"","title":"Health Outcomes by Neighborhood - Baltimore","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2012-07-17","conditions":"Stigma, Activity Space, Social Networks","enrollment":1651},{"nctId":"NCT07221396","phase":"NA","title":"LDART for Stimulant Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"Yale University","startDate":"2026-04-01","conditions":"Stimulant Use Disorder, Cocaine Use Disorder, Methamphetamine Use Disorder","enrollment":80},{"nctId":"NCT06871488","phase":"PHASE4","title":"Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants","status":"RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2026-03-05","conditions":"ADHD - Attention Deficit Disorder With Hyperactivity, Irritability, Aggression Childhood","enrollment":136},{"nctId":"NCT07125235","phase":"NA","title":"Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-02-09","conditions":"Behavioral Intervention, Viral Suppression of HIV Infection, ART Adherence","enrollment":270},{"nctId":"NCT07281378","phase":"NA","title":"Reducing Co-occurring Substance Use and HIV Risk Among Stimulant-using Men at High Risk for HIV in the United States of America.","status":"NOT_YET_RECRUITING","sponsor":"University of Florida","startDate":"2026-04-15","conditions":"Drug Use Disorders, PrEP Uptake, PrEP Adherence","enrollment":84},{"nctId":"NCT07226219","phase":"PHASE1","title":"Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease","status":"RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2025-11-25","conditions":"Sickle Cell Disease, Executive Dysfunction, Cognitive Impairment","enrollment":72},{"nctId":"NCT07461350","phase":"","title":"Stimulant and Polysubstance Use, Inflammation, and Sex Effects on Myocardial Disease in HIV","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-03-15","conditions":"HIV (Human Immunodeficiency Virus)","enrollment":400},{"nctId":"NCT05783817","phase":"PHASE2","title":"MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)","status":"RECRUITING","sponsor":"Carolyn Rodriguez","startDate":"2025-09-10","conditions":"Obsessive-Compulsive Disorder","enrollment":40},{"nctId":"NCT07443332","phase":"NA","title":"Culturally Adapted Contingency Management","status":"NOT_YET_RECRUITING","sponsor":"Yale University","startDate":"2026-03","conditions":"Stimulant Use Disorders","enrollment":70},{"nctId":"NCT03434509","phase":"NA","title":"Ongoing Tai Chi Training for Children With ADHD","status":"COMPLETED","sponsor":"Hugo W. Moser Research Institute at Kennedy Krieger, Inc.","startDate":"2017-11-02","conditions":"ADHD","enrollment":15},{"nctId":"NCT06788587","phase":"PHASE2","title":"Feasibility of Long-term, High-dose Stimulant for Methamphetamine Use Disorder","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2025-07-18","conditions":"Methamphetamine Abuse, Methamphetamine-dependence, Addiction","enrollment":80},{"nctId":"NCT06370481","phase":"NA","title":"HIV, Equity, and Addiction Training (HEAT) Program","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-01-29","conditions":"Substance Use Disorders, Hiv, Opioid Use Disorder","enrollment":30},{"nctId":"NCT07407114","phase":"NA","title":"Effects of Different Stimuli on Muscle Activation, Hand Grip Strength, Reaction Time, and Hand Function","status":"COMPLETED","sponsor":"Lokman Hekim University","startDate":"2023-03-30","conditions":"Upper Extremity Dysfunction","enrollment":80},{"nctId":"NCT07136363","phase":"NA","title":"RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry","status":"NOT_YET_RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2026-04-06","conditions":"HIV, Stimulant Use Disorder, Justice Involved Populations","enrollment":40},{"nctId":"NCT05972044","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)","status":"COMPLETED","sponsor":"Axsome Therapeutics, Inc.","startDate":"2023-07-06","conditions":"ADHD","enrollment":516},{"nctId":"NCT06790576","phase":"PHASE1","title":"Optimizing Transcranial Magnetic Stimulation for Stimulant Use Disorder","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2024-12-01","conditions":"Stimulant Use Disorder","enrollment":50},{"nctId":"NCT05854667","phase":"PHASE2","title":"Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2023-12-05","conditions":"Methamphetamine Abuse, Methamphetamine-dependence, Addiction, Substance","enrollment":440},{"nctId":"NCT07380412","phase":"NA","title":"A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications","status":"RECRUITING","sponsor":"Outliers, Inc.","startDate":"2025-08-12","conditions":"ADHD, Sleep Disturbance, Brain Fog","enrollment":90},{"nctId":"NCT05592119","phase":"","title":"Effect of Stimulant Medication on Loss of Control Eating in Youth With Attention Deficit/Hyperactivity Disorder","status":"COMPLETED","sponsor":"Nova Scotia Health Authority","startDate":"2023-01-11","conditions":"Loss of Control Eating, Attention Deficit/Hyperactivity Disorder","enrollment":10},{"nctId":"NCT06444360","phase":"NA","title":"Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults","status":"RECRUITING","sponsor":"Westat","startDate":"2025-11-04","conditions":"HIV","enrollment":360},{"nctId":"NCT07333339","phase":"","title":"A Brain-Computer Interface-Based Attention Training Program Compared With Methylphenidate and Citicoline","status":"COMPLETED","sponsor":"Uludag University","startDate":"2025-02-01","conditions":"Attention Deficit Hyperactivity Disorder (ADHD), Brain Computer Interface","enrollment":174},{"nctId":"NCT05776056","phase":"PHASE4","title":"Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-02-05","conditions":"Posttraumatic Stress Disorder (PTSD)","enrollment":70},{"nctId":"NCT06360419","phase":"PHASE3","title":"Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol","status":"COMPLETED","sponsor":"Axsome Therapeutics, Inc.","startDate":"2024-03-18","conditions":"Major Depressive Disorder","enrollment":346},{"nctId":"NCT05546515","phase":"PHASE2","title":"Suvorexant for Opioid/Stimulant Co-use","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2022-12-01","conditions":"Opioid Use Disorder, Stimulant Use Disorder","enrollment":20},{"nctId":"NCT05301361","phase":"PHASE1","title":"Sensitivity of the NIH Toolbox to Stimulant Treatment in Intellectual Disabilities","status":"ENROLLING_BY_INVITATION","sponsor":"University of California, Davis","startDate":"2023-02-01","conditions":"Intellectual Disability, Fragile X Syndrome, Down Syndrome","enrollment":68},{"nctId":"NCT04982796","phase":"PHASE1, PHASE2","title":"Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder","status":"RECRUITING","sponsor":"Portland VA Research Foundation, Inc","startDate":"2022-07-07","conditions":"Amphetamine-Related Disorders","enrollment":30},{"nctId":"NCT06221358","phase":"","title":"Pharmacogenomics of Stimulant Treatment Response","status":"RECRUITING","sponsor":"University of Calgary","startDate":"2024-04-01","conditions":"Attention-Deficit/ Hyperactivity Disorder (ADHD)","enrollment":400},{"nctId":"NCT07260734","phase":"","title":"AUGMENTED RESPONSE OF VOLATILE BIOMARKERS IN THE ASSESSMENT OF OESOPHAGOGASTRIC CANCER (AROMA2)","status":"NOT_YET_RECRUITING","sponsor":"Imperial College London","startDate":"2025-12-01","conditions":"OESOPHAGO-GASTRIC CARCINOMA, Oesophageal Adenocarcinoma, Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma","enrollment":6000},{"nctId":"NCT06878976","phase":"PHASE3","title":"Open-Label Safety Study of Solriamfetol in Subjects With Binge Eating Disorder","status":"ENROLLING_BY_INVITATION","sponsor":"Axsome Therapeutics, Inc.","startDate":"2025-02-20","conditions":"Binge-Eating Disorder","enrollment":300},{"nctId":"NCT06568367","phase":"PHASE3","title":"Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)","status":"RECRUITING","sponsor":"Axsome Therapeutics, Inc.","startDate":"2024-08-01","conditions":"Excessive Sleepiness, Shift-work Disorder","enrollment":520},{"nctId":"NCT06413433","phase":"PHASE3","title":"Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol","status":"RECRUITING","sponsor":"Axsome Therapeutics, Inc.","startDate":"2024-04-26","conditions":"Binge-Eating Disorder","enrollment":450},{"nctId":"NCT07238465","phase":"PHASE3","title":"Exploring Sympathetic Nervous System Function in Individuals With Down Syndrome","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2025-12","conditions":"Down Syndrome, Autonomic Dysfunction","enrollment":200},{"nctId":"NCT05185583","phase":"PHASE2","title":"Methylphenidate in Childhood Apraxia of Speech","status":"COMPLETED","sponsor":"Murdoch Childrens Research Institute","startDate":"2022-03-14","conditions":"Childhood Apraxia of Speech","enrollment":18},{"nctId":"NCT07216963","phase":"NA","title":"The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study","status":"NOT_YET_RECRUITING","sponsor":"Duke University","startDate":"2026-09","conditions":"Opioid Use Disorder, Overdose, Drug, Overdose","enrollment":400},{"nctId":"NCT06033365","phase":"NA","title":"Beginning Early and Assertive Treatment for Methamphetamine Use Disorder","status":"COMPLETED","sponsor":"Denver Health and Hospital Authority","startDate":"2023-04-11","conditions":"Methamphetamine Use Disorder","enrollment":192},{"nctId":"NCT07043452","phase":"EARLY_PHASE1","title":"Measuring Acute Drug Demand in Humans II","status":"WITHDRAWN","sponsor":"Johns Hopkins University","startDate":"2025-11-15","conditions":"Healthy Volunteers","enrollment":""},{"nctId":"NCT04501653","phase":"EARLY_PHASE1","title":"Precision Functional Brain Mapping in Psilocybin","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2021-06-01","conditions":"Psilocybin","enrollment":11},{"nctId":"NCT06513156","phase":"NA","title":"Continuum of Care in Hospitalized Patients With Opioid/Stimulant Use Disorder and Infectious Complications From Drug Use","status":"RECRUITING","sponsor":"Elana Rosenthal","startDate":"2024-10-01","conditions":"Opioid Use Disorder, Injection Related Infections, Stimulant Use Disorder","enrollment":304},{"nctId":"NCT03814356","phase":"PHASE1","title":"Stimulant Therapy Targeted to Individualized Connectivity Maps to Promote ReACTivation of Consciousness","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2020-08-24","conditions":"Brain Injury Traumatic Severe (Diagnosis), Coma, Consciousness, Level Altered","enrollment":10},{"nctId":"NCT05916339","phase":"PHASE4","title":"AWARE: Management of ADHD in Autism Spectrum Disorder","status":"RECRUITING","sponsor":"Daniel Coury","startDate":"2023-10-01","conditions":"ADHD, Autism Spectrum Disorder","enrollment":500},{"nctId":"NCT07219082","phase":"NA","title":"Behavioral Safety and Fentanyl Education: BSAFE","status":"NOT_YET_RECRUITING","sponsor":"San Francisco Department of Public Health","startDate":"2025-12-15","conditions":"Drug Overdose, Drug Overdose Accidental","enrollment":160},{"nctId":"NCT04903470","phase":"NA","title":"Defecation Patterns in Constipated Patients","status":"RECRUITING","sponsor":"The California Medical Innovations Institute, Inc.","startDate":"2022-12-19","conditions":"Constipation by Outlet Obstruction","enrollment":130},{"nctId":"NCT06564792","phase":"NA","title":"Contingency Management in HIV Care for Both Stimulant Use & ART Adherence","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2023-09-15","conditions":"Stimulant Use (Diagnosis), Hiv","enrollment":37},{"nctId":"NCT06038929","phase":"NA","title":"Effect of Vagal Nerve Stimulation on Gastric Motor Functions","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-09-01","conditions":"Depression, Epilepsy","enrollment":16},{"nctId":"NCT06899594","phase":"EARLY_PHASE1","title":"Psilocybin for Methamphetamine Addiction","status":"RECRUITING","sponsor":"Kevin Murnane","startDate":"2025-04-04","conditions":"Methamphetamine Use Disorder","enrollment":20},{"nctId":"NCT06646822","phase":"","title":"Prevalence, Awareness, Attitudes and Patterns of Stimulant Drug Use Among Students in Egyptian Universities","status":"ACTIVE_NOT_RECRUITING","sponsor":"Asmaa Ahmed Hamed Mohie Eldin","startDate":"2024-12-10","conditions":"Study of Stimulants in Egypt","enrollment":1500},{"nctId":"NCT04299490","phase":"PHASE2","title":"Effects of Experimental Sleep Disturbances on Receptor Function of Study Drug","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2020-11-11","conditions":"Sleep Disorder, Healthy","enrollment":148},{"nctId":"NCT05976984","phase":"","title":"Stimulant Overdose in the Medicaid Population: Who is at Risk, and When Are They at Risk","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2021-09-30","conditions":"Stimulant Overdose","enrollment":634939},{"nctId":"NCT05787847","phase":"NA","title":"Financial Incentives to Promote Stimulant Abstinence in a Community-Based Syringe Exchange Program","status":"COMPLETED","sponsor":"University of Vermont","startDate":"2024-02-14","conditions":"Stimulant Use","enrollment":27},{"nctId":"NCT06538584","phase":"PHASE1, PHASE2","title":"Dex +/- Caffeine Sedation in a Post-MRI Recovery in a Pediatric Population","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2024-09-09","conditions":"Enhanced Recovery After Surgery in a Pediatric Population","enrollment":100},{"nctId":"NCT06578429","phase":"NA","title":"Deep TMS of Neural Circuits Associated With Stimulant Use Disorder","status":"RECRUITING","sponsor":"Stanford University","startDate":"2025-03-15","conditions":"Methamphetamine Use Disorder, Transcranial Magnetic Stimulation","enrollment":30},{"nctId":"NCT06814275","phase":"NA","title":"Project neuroARTEMIS","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2025-04-29","conditions":"Stimulant Use, Human Immunodeficiency Virus (HIV), Depression","enrollment":189},{"nctId":"NCT05288751","phase":"NA","title":"Contingency Management for Opioid and Stimulant Use Disorders in Primary Care","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Minnesota","startDate":"2022-06-15","conditions":"Opioid Use Disorder, Stimulant Use Disorder","enrollment":56},{"nctId":"NCT06444256","phase":"PHASE2","title":"Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2024-07-25","conditions":"Stimulant Use Disorder","enrollment":20},{"nctId":"NCT04228276","phase":"NA","title":"Treating Stimulant Addiction With Repetitive Transcranial Magnetic Stimulation","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2021-02-05","conditions":"Stimulant Use Disorder, Substance-related Disorders","enrollment":30},{"nctId":"NCT03279952","phase":"PHASE4","title":"Neurophysiological Markers of Pediatric Irritability and Its Response to Intervention","status":"TERMINATED","sponsor":"Milton S. Hershey Medical Center","startDate":"2018-06-01","conditions":"ADHD","enrollment":11},{"nctId":"NCT07128485","phase":"NA","title":"Remote Fentanyl Test Strip Distribution and Education to Prevent Drug Overdose","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-09","conditions":"Accidental Overdose of Opiate","enrollment":100},{"nctId":"NCT07127237","phase":"EARLY_PHASE1","title":"Prucaloprida vs Bisacodyl as a Stimulant in Bowel Preparation for Video Colonoscopy in Adults","status":"NOT_YET_RECRUITING","sponsor":"Hospital de Clínicas Dr. Manuel Quintela","startDate":"2025-09","conditions":"Bowel Preparation","enrollment":124},{"nctId":"NCT07112105","phase":"NA","title":"Repetitive Transcranial Magnetic Stimulation Treatment of Stimulant Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-01-01","conditions":"Stimulant Use Disorder","enrollment":106},{"nctId":"NCT03511976","phase":"PHASE4","title":"Adaptive Response to Intervention (RTI) for Students With ADHD","status":"WITHDRAWN","sponsor":"Florida International University","startDate":"2018-05-14","conditions":"Attention Deficit Disorder With Hyperactivity","enrollment":""},{"nctId":"NCT05958017","phase":"NA","title":"reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)","status":"RECRUITING","sponsor":"University of Miami","startDate":"2025-03-04","conditions":"Stimulant Use Disorder, People Living With HIV, reSET","enrollment":500},{"nctId":"NCT07092059","phase":"NA","title":"Smartphone Services for Stimulant Use Disorder","status":"RECRUITING","sponsor":"DynamiCare Health","startDate":"2025-06-24","conditions":"Stimulant Use Disorder","enrollment":270},{"nctId":"NCT04281979","phase":"NA","title":"Effects of a Specific Substance in Smokers","status":"RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2020-02-25","conditions":"Smoking","enrollment":60},{"nctId":"NCT06221722","phase":"","title":"Predicting Treatment Outcomes in Refractory Constipation Through Brain Connectivity Evaluation","status":"RECRUITING","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2023-11-01","conditions":"Constipation - Functional, Refractory Constipation, Fluoxetine","enrollment":150},{"nctId":"NCT06609278","phase":"NA","title":"THRIVE: Culturally AdapTed Harm Reduction Intervention","status":"COMPLETED","sponsor":"Brittany Miller-Roenigk","startDate":"2025-04-02","conditions":"Opioid Use, Stimulant Use","enrollment":57},{"nctId":"NCT07061886","phase":"EARLY_PHASE1","title":"Drug Effects on Mood and Behavior - Expectancy","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2025-06-26","conditions":"LSD","enrollment":48},{"nctId":"NCT04907357","phase":"NA","title":"rTMS for Stimulant Use Disorders","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2022-02-04","conditions":"Cocaine Use Disorder, Methamphetamine Abuse, Cocaine Dependence","enrollment":129},{"nctId":"NCT04205487","phase":"NA","title":"PrEP Readiness Interventions for Supporting Motivation","status":"COMPLETED","sponsor":"Florida International University","startDate":"2020-10-16","conditions":"HIV Infections, Pre-exposure Prophylaxis, Substance Use Disorders","enrollment":70},{"nctId":"NCT06910605","phase":"NA","title":"Exploring Parameters of Driving Simulation in Relation to Drug Holidays in ADHD Patients","status":"RECRUITING","sponsor":"Stefan Lakämper","startDate":"2025-06-02","conditions":"ADHD - Attention Deficit Disorder With Hyperactivity, Driving Simulator Performance, ADHD","enrollment":26},{"nctId":"NCT06969066","phase":"NA","title":"Memory Training in Insomnia With Cognitive Impairment","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2024-11-01","conditions":"Cognitive Therapy/Methods, Insomnia Chronic, Cognitive Dysfunction","enrollment":70},{"nctId":"NCT06967922","phase":"NA","title":"Impact of Analytic-integrative Cognitive Behavioural Therapy on Acute Insomnia Disorder (Stress)","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2024-11-01","conditions":"Acute Insomnia Disorder","enrollment":70},{"nctId":"NCT06969053","phase":"NA","title":"Effect of MIT for CI With Anxiety","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2024-11-01","conditions":"Chronic Insomnia, Anxiety Disorders","enrollment":70},{"nctId":"NCT04273841","phase":"NA","title":"Impact of Sleep Deprivation and Caffeine in Medical Professionals","status":"TERMINATED","sponsor":"Walter Reed Army Institute of Research (WRAIR)","startDate":"2017-07-06","conditions":"Sleep Deprivation, Performance","enrollment":7},{"nctId":"NCT06968013","phase":"NA","title":"Effect of WBT for CI With Depression","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2024-11-01","conditions":"Chronic Insomnia, Depression Disorders","enrollment":84},{"nctId":"NCT06960759","phase":"PHASE2","title":"Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough","status":"NOT_YET_RECRUITING","sponsor":"University of Montana","startDate":"2025-08-01","conditions":"Chronic Cough (CC), Refractory Chronic Cough, Unexplained Chronic Cough","enrollment":150},{"nctId":"NCT05845333","phase":"","title":"Neurocognitive Abnormalities in Stimulant Abuse Among High-Risk Women","status":"RECRUITING","sponsor":"The Mind Research Network","startDate":"2022-08-01","conditions":"Stimulant Abuse, Criminal Behavior","enrollment":334},{"nctId":"NCT06923384","phase":"PHASE1","title":"SBI for PSM and PSD","status":"ENROLLING_BY_INVITATION","sponsor":"California State University, Long Beach","startDate":"2024-10-01","conditions":"Prescription Stimulant Misuse, Prescription Stimulant Diversion","enrollment":120},{"nctId":"NCT06221826","phase":"PHASE4","title":"MEXIDOL® in the Rehabilitation Treatment of Patients With Acute Cerebral Failure","status":"COMPLETED","sponsor":"Pharmasoft","startDate":"2023-04-17","conditions":"Ischemic Stroke, Acute","enrollment":60},{"nctId":"NCT05889702","phase":"","title":"Kentucky Access to Recovery Evaluation","status":"COMPLETED","sponsor":"Terry Bunn","startDate":"2023-07-03","conditions":"Substance Use Disorders, Treatment Adherence and Compliance","enrollment":458},{"nctId":"NCT06073340","phase":"","title":"The Longitudinal Study of Stimulant Use Disorder","status":"TERMINATED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2023-11-16","conditions":"Stimulant Use, Stimulant-Related Disorder, Healthy","enrollment":72},{"nctId":"NCT06905496","phase":"PHASE1","title":"Apnea of Prematurity Results in Respiratory Distress and Cyanosis. Caffeine Citrate Can Treat It.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nishtar Medical University","startDate":"2024-06-03","conditions":"Apnea of Prematurity","enrollment":114},{"nctId":"NCT05702021","phase":"NA","title":"Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2023-06-07","conditions":"Stimulant Use (Diagnosis)","enrollment":76},{"nctId":"NCT03420339","phase":"PHASE4","title":"Stimulant Effects on Disruptive Behavior","status":"RECRUITING","sponsor":"Matthew J O'Brien, PhD, BCBA-D","startDate":"2018-10-01","conditions":"Attention Deficit Hyperactivity Disorder, Problem Behavior","enrollment":10},{"nctId":"NCT06880146","phase":"NA","title":"Cross-validation of a Predictive Model of Response to Anti-TNF Alpha Based on Oxylipin Response in Rheumatoid Arthritis","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2025-03-15","conditions":"Rheumatoid Arthritis","enrollment":30},{"nctId":"NCT01140880","phase":"PHASE2","title":"Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men","status":"COMPLETED","sponsor":"Friends Research Institute, Inc.","startDate":"2010-05","conditions":"HIV Seroconversion, Stimulant Abuse","enrollment":170},{"nctId":"NCT04950660","phase":"PHASE4","title":"Oral Caffeine Use for Pain Management in AIS Patients After Spinal Fusion","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2019-12-11","conditions":"Adolescent Idiopathic Scoliosis","enrollment":61},{"nctId":"NCT06830018","phase":"NA","title":"Nanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-related Fatigue","status":"RECRUITING","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2025-01-23","conditions":"Cancer-related Fatigue， Gastric Cancer，Colorectal Cancer，Nano-crystalline Megestrol Acetate，Megestrol Acetate，First-line Treatment","enrollment":76},{"nctId":"NCT05290493","phase":"PHASE2","title":"NB-001 in Children and Adolescents With 22q11 Deletion Syndrome","status":"COMPLETED","sponsor":"Nobias Therapeutics, Inc.","startDate":"2022-02-10","conditions":"22q11 Deletion Syndrome","enrollment":37},{"nctId":"NCT05412758","phase":"NA","title":"Augmented Response of Volatile Biomarkers in Assessment of Oesophagogastric Cancer (AROMA 1 / BIORESOURCE)","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2022-02-28","conditions":"Volatile Organic Compounds, Microbiome, Microbioata","enrollment":648},{"nctId":"NCT06779825","phase":"","title":"Impact of Stimulants and In-Scanner Motion on Attentive Task Performance in ADHD (ADHD_NFB)","status":"NOT_YET_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2025-02","conditions":"ADHD","enrollment":30},{"nctId":"NCT06745960","phase":"NA","title":"Effect of Electrical Stimulation on Forward Head Posture","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-01","conditions":"Forward Head Posture, Rounded Shoulder Posture","enrollment":40},{"nctId":"NCT04240756","phase":"PHASE3","title":"Treating Parents with ADHD and Their Young Children Via Telehealth: a Hybrid Type I Effectiveness-Implementation Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, College Park","startDate":"2020-08-06","conditions":"ADHD, Parenting","enrollment":240},{"nctId":"NCT03098563","phase":"PHASE2","title":"Maximizing Analgesia to Reduce Pain in Knee Osteoarthritis","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2017-11-01","conditions":"Knee Osteoarthritis","enrollment":58},{"nctId":"NCT06076564","phase":"","title":"Leveraging Psychological Autopsies to Accelerate Research Into Stimulant Overdose Mortality","status":"COMPLETED","sponsor":"San Francisco Department of Public Health","startDate":"2022-06-06","conditions":"Stimulant Overdose, Overdose Accidental, Overdose Cocaine","enrollment":176},{"nctId":"NCT04885166","phase":"NA","title":"Preventing Prescription Stimulant Diversion and Medication Misuse Via a Web-Based Simulation Intervention","status":"COMPLETED","sponsor":"Trinity College","startDate":"2021-05-04","conditions":"Prescription Drug Abuse (Not Dependent), Intentional Misuse","enrollment":249}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["CNS Simulant RCT phase (second phase)"],"phase":"marketed","status":"active","brandName":"CNS Stimulant","genericName":"CNS Stimulant","companyName":"Milton S. Hershey Medical Center","companyId":"milton-s-hershey-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CNS Stimulants, such as Extended Release Methylphenidate (OROS-Methylphenidate), are used to treat conditions including Attention Deficit Disorder With Hyperactivity and Substance Use Disorders. They are also being studied for their potential in addressing Opioid Use Disorder and Overdose.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}